Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helene Johansson

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Plos One|May 10, 2017
Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expressionAhmad Karadagi, Helene Johansson, Helen Zemack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2015
Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cellsNicole Marquardt, Vivien Béziat, Sanna Nyström, et al.
Lancet (London, England)|December 8, 2018
Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trialUlf Näslund, Nawi Ng, Anna Lundgren, et al.
Hepatology (Baltimore, Md.)|November 1, 2021
Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinomaChristine L Zimmer, Iva Filipovic, Martin Cornillet, et al.
Nature Metabolism|July 6, 2023
Human resident liver myeloid cells protect against metabolic stress in obesityEmelie Barreby, Benedikt Strunz, Sebastian Nock, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Plos One|May 10, 2017
Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expressionAhmad Karadagi, Helene Johansson, Helen Zemack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2015
Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cellsNicole Marquardt, Vivien Béziat, Sanna Nyström, et al.
Lancet (London, England)|December 8, 2018
Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trialUlf Näslund, Nawi Ng, Anna Lundgren, et al.
Hepatology (Baltimore, Md.)|November 1, 2021
Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinomaChristine L Zimmer, Iva Filipovic, Martin Cornillet, et al.
Nature Metabolism|July 6, 2023
Human resident liver myeloid cells protect against metabolic stress in obesityEmelie Barreby, Benedikt Strunz, Sebastian Nock, et al.
Pageof 4